Idrossiprolinuria E Neoplasia Prostatica

Mundy A. R. : Urinary hydroxyproline excretion in carcinoma of the prostate. A comparison of 4 different modes of assessment and its role as a marker. Brit. J. Urol., 51; 570 (1979).

Guzzo C. , Pachas E. , Pinals R. , Krant M. J. : Urinary hydroxyproline excretion in patients with cancer. Cancer, 24; 382 (1969).

Cuschieri A. : Urinary hydroxyproline excretion in early and advanced breast cancer: a sequential study. Brit. J. Urol., 60; 800 (1973).

Poyles T. J. , Leese C. C. , Bondy P. K. : Hydroxyproline excretion in patients with breast cancer: response to treatment. Brit. Med. J., 2; 164 (1975).

Gielen F. , Dequeker J. , Drochmans A. , Wildiers J. , Merlevede M. : Relevance of hydroxyproline excretion to bone metastasis in breast cancer. Brit. J. Cancer, 34; 279 (1976).

Bishop M. C. , Fellows G. J. : Urine hydroxiproline excretion a marker of bone metastasis in prostatic carcinoma. Brit. J. Urol., 49; 711 (1977).

Goverde B. C. , Veenkamp F. J. : Routine assay of total urinary hydroxyproline based on resin catalyzed hydrolysis. Clin. Chim. Acta, 41; 29–40 (1972).

Stegeman H. : Z. Physiol. Chem., 311; 41 (1958).

Mongerstern S. , Kessler F. , Averbach J. : Clin. Chem., 11; 876 (1965).

Bonadonna G. , Merlino M. J. , Myers W. P. , Sonenberg M. : Urinary hydroxyproline and calcium metabolism in patients with cancer. N. Engl. J. Med., 275; 298 (1966).

Moppan M. , Wax S. H. , Kim H. , Wang J. C. , Tobin M. S. : Urinary hydroxyproline excretion as a marker of osseous metastasis in carcinoma of the prostate. J. Urol., 123; 694 (1980).

Gasser A. B. , Depierre , Mermillod B. , Couvoisier B. : Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis. Brit. J. Cancer, 45; 477 (1982).

Scalella P. : Interference by iodinated contrast media in total urinary hydroxyproline measurement. Lancet, 1; 17 (1982).